|1.||Bilgiç, Gökhan: 1 article (03/2002)|
|2.||Pata, Cengiz: 1 article (03/2002)|
|3.||Eskandari, Gülçin: 1 article (03/2002)|
|4.||Konca, Kamuran: 1 article (03/2002)|
|5.||Oztürk, Candan: 1 article (03/2002)|
|6.||Yazar, Aziz: 1 article (03/2002)|
02/01/1989 - "A vaccination experiment using plasma-derived Hevac-B anti-hepatitis vaccine was conducted on two groups at high risk of HBV infection: hospital staff and hemodialyzed subjects. "
01/01/1990 - "In reporting the preliminary data on the anti-B hepatitis vaccination study, the paper compares the two plasma-derived vaccines on the market, Pasteur Hevac-B and HB-Vax M.S.D. "
06/01/1991 - "The anti-hepatitis vaccination with HBVax and HEVAC-B vaccines was used on 142 professional students and 996 hospital workers. "
02/01/1989 - "[Hepatitis B vaccination with the plasma-derived Hevac-B Pasteur vaccine. "
01/01/1989 - "135 subjects, belonging to the sanitary staff and the dialyzed patients (high-risk classes) of the Ospedale Maggiore in Crema, have been vaccinated against hepatitis B with Hevac B vaccine produced by Pasteur firm. "
04/25/1987 - "6162 Swiss hospital employees were vaccinated against hepatitis B from 1982-1984 with Hevac B Pasteur vaccine. "
04/25/1987 - "[The hepatitis B vaccination campaign carried out from 1982 to 1984 using the Hevac B Pasteur vaccine among 6162 employees of Vaud hospitals]."
01/01/1986 - "The authors describe a 15-month follow-up of twenty-nine nurse students vaccinated against hepatitis B with Hevac B Pasteur. "
01/01/1983 - "The HB vaccine which is manufactured by Institut Pasteur Production under the name HEVAC B degrees is now used world-wide for the prophylaxis of hospital acquired infection in developed countries and for the prevention of maternal-infant transmission in the endemic countries of Asia and Africa."
01/01/1994 - " Recognizing the risk of infection, it was planned to offer free vaccinations against hepatitis B using the Hevac B Pasteur plasma-derived vaccine to all hospital personnel. "
05/01/1985 - "[Immunological and epidemiological effectiveness of the HEVAC B vaccine against hepatitis B in a group at enhanced risk of infection]."
01/01/1992 - "From the data, GenHevac B vaccine is expected to be as effective as Hevac B vaccine for controlling hepatitis B infection."
01/01/1989 - "Three hepatitis B infections were identified in HB-VAX recipients, but no one in individuals vaccined with HEVAC-B. "
|4.||Renal Insufficiency (Renal Failure)
02/01/1991 - "Following the demonstration of a fully satisfactory immunogenic activity of a hepatitis B vaccination protocol consisting of three doses of Hevac B Pasteur vaccine given at 3,5 and 11 months of age, it was possible to administer this vaccine at the same times as the vaccinations for diphtheria, tetanus and polio which are mandatory in Italy at those ages. "
|3.||Hepatitis B Vaccines (Hepatitis B Vaccine)
|5.||GenHevac B Pasteur
|7.||Hepatitis B Surface Antigens (HBsAg)
|8.||Antihypertensive Agents (Antihypertensives)
|9.||Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
|10.||Green Cross HB vaccine